Rights issue in Karo Bio (SE) — SEK 325 million

Carnegie acted as sole lead manager in the rights issue of SEK 325 million. Karo Bio is a drug discovery and development company specialising in endocrinology and addressing nuclear receptors as target proteins for the development of novel pharmaceuticals.December, 2010.